126 related articles for article (PubMed ID: 38311062)
41. Down-regulation of cylindromatosis protein phosphorylation by BTK inhibitor promotes apoptosis of non-GCB-diffuse large B-cell lymphoma.
Xu X; Wei T; Zhong W; Ang R; Lei Y; Zhang H; Li Q
Cancer Cell Int; 2021 Apr; 21(1):195. PubMed ID: 33827598
[TBL] [Abstract][Full Text] [Related]
42. Mechanisms of 4-hydroxy-2-nonenal induced pro- and anti-apoptotic signaling.
Chaudhary P; Sharma R; Sharma A; Vatsyayan R; Yadav S; Singhal SS; Rauniyar N; Prokai L; Awasthi S; Awasthi YC
Biochemistry; 2010 Jul; 49(29):6263-75. PubMed ID: 20565132
[TBL] [Abstract][Full Text] [Related]
43. Aberrant localization of apoptosis protease activating factor-1 in lipid raft sub-domains of diffuse large B cell lymphomas.
Hirpara JL; Loh T; Ng SB; Chng WJ; Pervaiz S
Oncotarget; 2016 Dec; 7(51):83964-83975. PubMed ID: 27863378
[TBL] [Abstract][Full Text] [Related]
44. Role of mitogen-activated protein kinases in 4-hydroxy-2-nonenal-induced actin remodeling and barrier function in endothelial cells.
Usatyuk PV; Natarajan V
J Biol Chem; 2004 Mar; 279(12):11789-97. PubMed ID: 14699126
[TBL] [Abstract][Full Text] [Related]
45. Iron oxide nanoparticles inhibit tumor growth by ferroptosis in diffuse large B-cell lymphoma.
Huang QT; Hu QQ; Wen ZF; Li YL
Am J Cancer Res; 2023; 13(2):498-508. PubMed ID: 36895978
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines.
Farina FM; Inguscio A; Kunderfranco P; Cortesi A; Elia L; Quintavalle M
Cell Death Dis; 2017 Jun; 8(6):e2890. PubMed ID: 28640256
[TBL] [Abstract][Full Text] [Related]
47. Revealing mechanisms of selective, concentration-dependent potentials of 4-hydroxy-2-nonenal to induce apoptosis in cancer cells through inactivation of membrane-associated catalase.
Bauer G; Zarkovic N
Free Radic Biol Med; 2015 Apr; 81():128-44. PubMed ID: 25619142
[TBL] [Abstract][Full Text] [Related]
48. FSP1-mediated ferroptosis in cancer: from mechanisms to therapeutic applications.
Gao R; Wang J; Huang J; Wang T; Guo L; Liu W; Guan J; Liang D; Meng Q; Pan H
Apoptosis; 2024 Apr; ():. PubMed ID: 38615304
[TBL] [Abstract][Full Text] [Related]
49. Integrated chemical and genetic screens unveil FSP1 mechanisms of ferroptosis regulation.
Nakamura T; Mishima E; Yamada N; Mourão ASD; Trümbach D; Doll S; Wanninger J; Lytton E; Sennhenn P; Nishida Xavier da Silva T; Angeli JPF; Sattler M; Proneth B; Conrad M
Nat Struct Mol Biol; 2023 Nov; 30(11):1806-1815. PubMed ID: 37957306
[TBL] [Abstract][Full Text] [Related]
50. Klotho, an anti-aging gene, acts as a tumor suppressor and inhibitor of IGF-1R signaling in diffuse large B cell lymphoma.
Zhou X; Fang X; Jiang Y; Geng L; Li X; Li Y; Lu K; Li P; Lv X; Wang X
J Hematol Oncol; 2017 Feb; 10(1):37. PubMed ID: 28153033
[TBL] [Abstract][Full Text] [Related]
51. Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B-cell lymphomas, determined by a highly sensitive in vitro apoptosis assay.
Cillessen SA; Meijer CJ; Ossenkoppele GJ; Castricum KC; Westra AH; Niesten P; Muris JJ; Nijdam HF; van der Hem KG; Flens M; Hooijberg E; Oudejans JJ
Br J Haematol; 2006 Aug; 134(3):283-93. PubMed ID: 16848771
[TBL] [Abstract][Full Text] [Related]
52. Sirt6 promotes tumorigenesis and drug resistance of diffuse large B-cell lymphoma by mediating PI3K/Akt signaling.
Yang J; Li Y; Zhang Y; Fang X; Chen N; Zhou X; Wang X
J Exp Clin Cancer Res; 2020 Jul; 39(1):142. PubMed ID: 32711549
[TBL] [Abstract][Full Text] [Related]
53. Phase separation of FSP1 promotes ferroptosis.
Nakamura T; Hipp C; Santos Dias Mourão A; Borggräfe J; Aldrovandi M; Henkelmann B; Wanninger J; Mishima E; Lytton E; Emler D; Proneth B; Sattler M; Conrad M
Nature; 2023 Jul; 619(7969):371-377. PubMed ID: 37380771
[TBL] [Abstract][Full Text] [Related]
54. The Appearance of 4-Hydroxy-2-Nonenal (HNE) in Squamous Cell Carcinoma of the Oropharynx.
Jakovčević A; Žarković K; Jakovčević D; Rakušić Z; Prgomet D; Waeg G; Šunjić SB; Žarković N
Molecules; 2020 Feb; 25(4):. PubMed ID: 32079077
[TBL] [Abstract][Full Text] [Related]
55. Activation of unfolded protein response overcomes Ibrutinib resistance in diffuse large B-cell lymphoma.
Zhang XT; Hu XB; Wang HL; Kan WJ; Xu L; Wang ZJ; Xiang YQ; Wu WB; Feng B; Li JN; Gao AH; Dong TC; Xia CM; Zhou YB; Li J
Acta Pharmacol Sin; 2021 May; 42(5):814-823. PubMed ID: 32855532
[TBL] [Abstract][Full Text] [Related]
56. NEMO-binding domain peptide inhibits constitutive NF-κB activity and reduces tumor burden in a canine model of relapsed, refractory diffuse large B-cell lymphoma.
Gaurnier-Hausser A; Patel R; Baldwin AS; May MJ; Mason NJ
Clin Cancer Res; 2011 Jul; 17(14):4661-71. PubMed ID: 21610150
[TBL] [Abstract][Full Text] [Related]
57. FOXM1-induced upregulation of lncRNA OR3A4 promotes the progression of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway.
Meng H; Zhao B; Wang Y
Exp Mol Pathol; 2020 Aug; 115():104451. PubMed ID: 32417392
[TBL] [Abstract][Full Text] [Related]
58. ROS-Dependent Lipid Peroxidation and Reliant Antioxidant Ferroptosis-Suppressor-Protein 1 in Rheumatoid Arthritis: a Covert Clue for Potential Therapy.
Xie Z; Hou H; Luo D; An R; Zhao Y; Qiu C
Inflammation; 2021 Feb; 44(1):35-47. PubMed ID: 32920707
[TBL] [Abstract][Full Text] [Related]
59. FAS (CD95) mutations are rare in gastric MALT lymphoma but occur more frequently in primary gastric diffuse large B-cell lymphoma.
Wohlfart S; Sebinger D; Gruber P; Buch J; Polgar D; Krupitza G; Rosner M; Hengstschläger M; Raderer M; Chott A; Müllauer L
Am J Pathol; 2004 Mar; 164(3):1081-9. PubMed ID: 14982861
[TBL] [Abstract][Full Text] [Related]
60. 4-hydroxy-2-nonenal-protein adducts and apoptosis in murine lung cells after acute ozone exposure.
Kirichenko A; Li L; Morandi MT; Holian A
Toxicol Appl Pharmacol; 1996 Dec; 141(2):416-24. PubMed ID: 8975766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
